# Endothelialized ePTFE Graft by Nanobiotechnology

> **NCT02002104** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 6 (actual)

## Conditions studied

- The Apparatus for Processing the Tubular Graft Modification Will be Designed and Evaluated.
- The On-site Capturing of the Endothelial (Progenitor) Cells by Peptide-mediated Selective Adhesion in Vitro and in Vivo Will Also be Elucidated.
- The Patency Rate of ITRI-made Artificial Blood Vessels Will be Evaluated by the Porcine Animal Model.

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02002104
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002104, "Endothelialized ePTFE Graft by Nanobiotechnology". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02002104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*